01.09.2025
TAALERI BIOINDUSTRY PRESS RELEASE 1 SEPTEMBER 2025 AT 10:00 (EEST)
Taaleri Bioindustry invests EUR 10 million in Finnish Food Factory to support its growth in plant-based dairy alternatives
Taaleri Bioindustry Fund I is investing EUR 10 million in Finnish Food Factory, a rapidly growing contract manufacturer of plant-based dairy products. The company specialises in the production of plant-based dairy alternatives for well-established global and Nordic brands, including Fazer. Finnish Food Factory has increased its turnover more than tenfold from 2020 (EUR 1.2 million) to 2024 (EUR 13.5 million). This growth is underpinned by a broad customer base and the company’s ability to deliver high-quality, competitive products efficiently and on schedule.
With this investment, Finnish Food Factory is poised to expand its production capabilities, driving long-term growth and broader market reach. Through its investment, the Article 9 fund is supporting the transition towards more sustainable, plant-based dairy production. The carbon footprint of oat milk is significantly lower than conventionally produced cow’s milk.
“We are pleased to begin our collaboration with Finnish Food Factory. With its experienced team, the company has achieved successful growth in both local and international markets while consistently delivering reliable production and value-add to its global customers,” says Marjatta Rytömaa, Managing Director at Taaleri Bioindustry.
“Finnish raw materials – particularly oats – have become a staple in consumers’ diets. With many years of expertise in plant-based products, the cornerstone of our operations is efficient, innovative and reliable production. We are excited to welcome Taaleri Bioindustry as our growth partner,” says Tuomas Kukkonen, Chair of the Board at Finnish Food Factory.
The investment is Taaleri Bioindustry Fund I’s sixth investment. The fund has raised over EUR 100 million in commitments, of which approximately half has been deployed.
For further information, please contact:
Marjatta Rytömaa, Managing Director, Taaleri Bioindustry, +358 44 765 1562, marjatta.rytomaa@taaleri.com
Taaleri Bioindustry in brief
Taaleri Bioindustry invests in growth companies. We accelerate the growth of compelling solutions in the bioeconomy and circular economy markets. We are a frontrunner in accelerating the shift from fossil-based economy to renewable materials or circular business models.
Taaleri Bioindustry is part of Taaleri Group. Taaleri is a specialist in investments, private asset management and non-life insurance, powering change with capital. Taaleri has EUR 2.7 bn of assets under management in its private equity funds, co-investments and single-asset vehicles. The company employs approximately 130 people. Taaleri Plc is listed on Nasdaq Helsinki.